News | 12.18.19
AVLS Advises That CMS Will Require Mandatory Prior Authorization for Vein Ablation in Hospital Outpatient Setting
December 18, 2019—The American Vein and Lymphatic Society (AVLS) advised its members who practice in the hospital outpatient setting (“Place of Service 22”) that in the 2020 Medicare Hospital Outpatient Final Rule issued in November, the Centers for Medicare & Medicaid Services (CMS) affirmed that effective July 1, 2020, vein ablation will require (in almost all cases) prior authorization in the formal Hospital Outpatient Prospective Payment System setting.
News | 11.13.17
Medtronic's VenaSeal Closure System Receives New CPT Codes
November 13, 2017—Medtronic has advised that their VenaSeal closure system received a favorable new CPT code as a level 4 vascular procedure as part of the calendar year 2018 Medicare Physician Fee Schedule and Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems final rules issued by the US Centers for Medicare & Medicaid Services.
News | 08.15.16
SVS and AVF Respond to Findings of MEDCAC Panel on Lower Extremity Chronic Venous Disease
August 15, 2016—The Society for Vascular Surgery (SVS) and the American Venous Forum (AVF) announced that vascular surgeons and vein specialists representing the two organizations presented their support for newer lower extremity chronic venous disease (LECVD) treatments at the July 20 Medicare Evidence Development & Coverage Advisory Committee (MEDCAC) panel hearing on treatment strategies for patients with LECVD.
News | 08.11.16
MEDCAC and AHRQ Find Evidence Is Insufficient to Support Interventional Treatments of Lower-Extremity Chronic Venous Disease
August 10, 2016—The score sheet on panelist voting from the July 20 Centers for Medicare & Medicaid Services (CMS) Medicare Evidence Development & Coverage Advisory Committee (MEDCAC) meeting on treatment strategies for patients with lower extremity chronic venous disease (LECVD) is now available on the CMS website here. Overall, the MEDCAC panelists expressed low confidence in the sufficiency of evidence to support a recommendation for national CMS coverage of interventions to treat LECVD.
News | 07.14.16
SVS Seeks Reconsideration of CMS's Proposed Rule Changes Related to MACRA
July 13, 2016—The Society for Vascular Surgery (SVS) announced that the society has sent a letter to the US Centers for Medicare & Medicaid Services (CMS) urging changes in the way CMS proposes to pay physicians and specialists. According to SVS, the current proposed rule impacts small practices negatively, is too complex, and lacks opportunity for specialists to participate in alternative payment models.
News | 08.04.15
CMS Reclassifies EVAR and Improves Reimbursement
August 3, 2015—The Centers for Medicare & Medicaid Services (CMS) reclassification of endovascular abdominal aneurysm repair (EVAR) to a new Medicare Severity Diagnosis-Related Group (MS-DRG) classification will result in increased hospital reimbursement for these procedures.
News | 07.08.15
CMS Issues Proposed Rule Updating Physician Fee Schedule
July 8, 2015—The Centers for Medicare & Medicaid Services (CMS) released the first proposed update to the physician payment schedule since the repeal of the Sustainable Growth Rate through the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA).
News | 07.07.15
CMS and AMA Initiatives Will Help Providers Prepare for ICD-10
July 6, 2015—The Centers for Medicare & Medicaid Services (CMS) and the American Medical Association (AMA) announced efforts to continue to help physicians get ready ahead of the October 1 deadline when the nation switches its International Classification of Diseases (ICD) coding for medical diagnoses and inpatient hospital procedures from ICD-9 to ICD-10.
News | 07.02.15
CMS Proposed Rule Would Modify "Two-Midnight" Policy
July 2, 2015—The Centers for Medicare & Medicaid Services (CMS) has issued a proposed rule that would revise a number of provisions for calendar year 2016, including changes to the hospital inpatient prospective payment system's “two-midnight” rule under the short inpatient hospital stay policy and the related -0.2% payment adjustment.
News | 06.22.15
CMS Approves Transitional Pass-Through Reimbursement for BioSentry Tract Sealant System
June 22, 2015—Surgical Specialties Corporation announced that the Centers for Medicare & Medicaid Services (CMS) approved a transitional pass-through payment for the company’s BioSentry tract sealant system under the Medicare hospital outpatient prospective payment system.
News | 01.26.15
HHS Sets Goals to Move Medicare's Fee-for-Service Model Away From Quantity to Quality
January 26, 2015—The US Department of Health and Human Services announced that Secretary Sylvia M. Burwell has outlined measurable goals and a timeline to move the Medicare program, and the health care system at large, toward paying providers based on the quality, rather than the quantity of care they give patients. Secretary Burwell presented these goals in a meeting with 24 representatives for consumers, insurers, providers, and businesses.
News | 12.03.13
CMS Finalizes Physician Payment Rates for 2014
November 27, 2013—The Centers for Medicare & Medicaid Services (CMS) announced the issuance of a rule that finalizes payment rates and policies for 2014, including a major proposal to support care management outside of the routine office interaction as well as other policies to promote high-quality care and efficiency in Medicare.
News | 09.17.13
SCAI Opposes Rules Proposed by CMS Regarding PCI Outpatient Payments and the Physician Fee Schedule for Out-of-Hospital Peripheral Procedures
September 13, 2013—The Society for Cardiovascular Angiography and Interventions advised in its weekly bulletin that the society has submitted comments to the Centers for Medicare & Medicaid Services (CMS) regarding concerns with the 2014 Hospital Outpatient Prospective Payment System (HOPPS) proposed rule.
News | 08.07.13
Cook's Zilver PTX Returns to Market and Gains Additional CMS Reimbursement
August 7, 2013—Cook Medical (Indianapolis, IN) has resumed shipment of its Zilver PTX paclitaxel-eluting peripheral stent after addressing a delivery catheter issue that led the company to issue a voluntary recall of the platform earlier this year.
News | 03.07.13
Medtronic's Symplicity Renal Denervation System Included in FDA-CMS Parallel Review Pilot Program
March 6, 2013—Medtronic, Inc. (Minneapolis, MN) announced that the company's Symplicity renal denervation system for treatment-resistant hypertension has been accepted into the parallel review program of the US Food and Drug Administration (FDA) and the Centers for Medicare & Medicaid Services (CMS).
News | 02.04.13
CMS Issues Final Financial Disclosure Rule Intended to Increase Transparency in Health Care
February 1, 2013—The Centers for Medicare & Medicaid Services (CMS) announced the issuance of a final rule intended to increase public awareness of financial relationships between drug and device manufacturers and certain health care providers.
News | 12.14.11
CMS Proposals Seek to Increase Transparency In Health Care
December 14, 2011—The Centers for Medicare & Medicaid Services (CMS) announced a proposed rule that is intended to increase public awareness of financial relationships between drug and device manufacturers and certain health care providers. The agency stated that this step was undertaken as part of implementing the Affordable Care Act, which is designed to increase transparency in the health care system while leading to better care at lower costs.